- Urological aspects of the metabolic syndromeJan Hammarsten
Department of Surgery, Section of Urology, Central Hospital, Rosenborgsgatan 2, S 652 30 Karlstad, Sweden
Nat Rev Urol 8:483-94. 2011..Urologists need to be aware of the effect that the metabolic syndrome has on urological disorders and should transfer this knowledge to their patients...
- A higher prediagnostic insulin level is a prospective risk factor for incident prostate cancerJ Hammarsten
Department of Surgery, Section of Urology, Central Hospital, Karlstad, Sweden
Cancer Epidemiol 34:574-9. 2010..The present findings also seem to confirm that prostate cancer is a component of the metabolic syndrome. Finally, our data generate the hypothesis that the metabolic syndrome conceals early prostate cancer...
- Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancerJan Hammarsten
Department of Urology, Central Hospital, Halmstad, Sweden
Blood Press 13:47-55. 2004....
- Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancerJan Hammarsten
Department of Urology, Central Hospital, SE 30185 Halmstad, Sweden
Eur J Cancer 41:2887-95. 2005..Furthermore, our data suggest that the insulin level could be used as a marker of prostate cancer prognosis and tumour aggressiveness, regardless of the patient's prostate cancer stage, cancer grade and PSA level...
- Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasiaJ Hammarsten
Department of Urology, Skaraborg Hospital, Skovde, Sweden
Prostate Cancer Prostatic Dis 12:160-5. 2009..Our findings also seem to confirm the metabolic syndrome hypothesis. The metabolic syndrome and its major endocrine aberration, hyperinsulinaemia, are possible primary events in BPH...
- Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancerJan Hammarsten
Department of Urology, Halland, Varberg Hospital, Varberg, Sweden
Scand J Urol Nephrol 36:330-8. 2002..If the hypothesis is true, men with fast-growing BPH would have a more advanced clinical prostate cancer...
- Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasiaJ Hammarsten
Urological Section, Department of Surgery, Varberg Hospital, Varberg, Sweden
Eur Urol 39:151-8. 2001..To test the hypothesis of hyperinsulinaemia as a causal factor for the development of benign prostatic hyperplasia (BPH)...
- One-third of the Swedish male population over 50 years of age suffers from lower urinary tract symptomsJohan Stranne
Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
Scand J Urol Nephrol 43:199-205. 2009..To investigate the prevalence of and restrictions in various parts of daily life due to lower urinary tract symptoms (LUTS) in an unselected Swedish male population...
- Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5Per Olov Hedlund
Department of Urology, Karolinska University Hospital Solna, Sweden
Scand J Urol Nephrol 42:220-9. 2008..The aim of the study was to compare anticancer efficacy and adverse events, especially cardiovascular events...
- Preoperative skin testing of materials used in surgical proceduresRosalie Hammarsten
Central Operating Department, Varberg Hospital, Sweden
AORN J 77:762-6, 769-71. 2003..Skin reactions after preoperative skin testing occurred in 3% to 50% of patients with atopic or contact eczema, allergy, or asthma in their medical history...